These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


564 related items for PubMed ID: 26701851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y, Liu YH, Hu YY, Chen L, Li JM.
    World J Gastroenterol; 2016 Oct 14; 22(38):8528-8539. PubMed ID: 27784965
    [Abstract] [Full Text] [Related]

  • 6. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q, Yuan F, Lu F, Zhang B, Chen T, Chen X, Cheng Y, Li N, Ma L, Tong T.
    Oncotarget; 2015 Mar 10; 6(7):4733-44. PubMed ID: 25749381
    [Abstract] [Full Text] [Related]

  • 7. SATB1 and 2 in colorectal cancer.
    Brocato J, Costa M.
    Carcinogenesis; 2015 Feb 10; 36(2):186-91. PubMed ID: 25543122
    [Abstract] [Full Text] [Related]

  • 8. SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.
    Zhang J, Zhang B, Zhang X, Sun Y, Wei X, McNutt MA, Lu S, Liu Y, Zhang D, Wang M, Lin Z, Niu N.
    PLoS One; 2013 Feb 10; 8(1):e47902. PubMed ID: 23326301
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
    Ye Y, Xiao L, Wang SJ, Yue W, Yin QS, Sun MY, Xia W, Shao ZY, Zhang H.
    Oncotarget; 2016 Jan 26; 7(4):3921-33. PubMed ID: 26646797
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M, Iguchi T, Nambara S, Saito T, Komatsu H, Sakimura S, Hirata H, Uchi R, Takano Y, Shinden Y, Eguchi H, Masuda T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
    Ann Surg Oncol; 2015 Dec 26; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [Abstract] [Full Text] [Related]

  • 11. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K, Liu X, Xu T, Sun L, Qin J, He B, Pan Y, Sun H, Wang S.
    Mol Cancer; 2019 Sep 06; 18(1):135. PubMed ID: 31492160
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT, Fan Q, Zhu Z, Kwan SY, Chen L, Chen JH, Ying ZL, Zhou Y, Gu W, Wang LH, Cheng WW, Zeng J, Wan XP, Mok SC, Wong KK, Bao W.
    Oncotarget; 2015 Oct 13; 6(31):31702-20. PubMed ID: 26397136
    [Abstract] [Full Text] [Related]

  • 16. Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients.
    Liu TR, Xu LH, Yang AK, Zhong Q, Song M, Li MZ, Hu LJ, Chen FJ, Hu ZD, Han P, Zeng MS.
    PLoS One; 2012 Oct 13; 7(7):e40704. PubMed ID: 22815795
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.
    Wang S, Zhou J, Wang XY, Hao JM, Chen JZ, Zhang XM, Jin H, Liu L, Zhang YF, Liu J, Ding YQ, Li JM.
    J Pathol; 2009 Sep 13; 219(1):114-22. PubMed ID: 19557828
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.